Skip to main content
Year archive

HLB INC. — 2025 filings

All 55 regulatory filings released by HLB INC. (028300) in 2025, sourced directly from the official regulator.

55 Filings
2025 Period
2025 filings (55)
Filing Released Lang
[기재정정]주요사항보고서(회사합병결정)
M&A Activity
2025-12-31 Korean
증권발행실적보고서(합병등)
M&A Activity
2025-12-31 Korean
주요사항보고서(신주인수권부사채권발행결정)
Regulatory Filings
2025-11-03 Korean
투자설명서
Regulatory Filings
2025-10-16 Korean
전환가액의조정
Regulatory Filings
2025-10-16 Korean
증권발행결과(자율공시)
Regulatory Filings
2025-10-02 Korean
전환사채(해외전환사채포함)발행후만기전사채취득
Regulatory Filings
2025-10-01 Korean
[기재정정]주요사항보고서(회사합병결정)
Regulatory Filings
2025-09-29 Korean
[기재정정]증권신고서(합병)
Regulatory Filings
2025-09-29 Korean
주요사항보고서(전환사채권발행결정)
Regulatory Filings
2025-09-24 Korean
주주명부폐쇄기간또는기준일설정
M&A Activity
2025-09-18 Korean
증권신고서(합병)
M&A Activity
2025-09-18 Korean
[첨부추가]주요사항보고서(회사합병결정)
M&A Activity
2025-09-17 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2025-09-16 Korean
전환사채(해외전환사채포함)발행후만기전사채취득
Capital/Financing Update
2025-09-08 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change
2025-09-03 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2025-09-01 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2025-09-01 Korean
증권발행결과(자율공시)
Share Issue/Capital Change
2025-08-28 Korean
지속가능경영보고서등관련사항(자율공시)
Report Publication Announcement
2025-08-28 Korean
주요사항보고서(전환사채권발행결정)
Capital/Financing Update
2025-08-20 Korean
반기보고서 (2025.06)
Interim / Quarterly Report H1 2025
2025-08-13 Korean
[기재정정]주요사항보고서(회사합병결정)
M&A Activity
2025-08-01 Korean
기타경영사항(자율공시) (회사합병결정 철회에 관한 사항)
M&A Activity
2025-08-01 Korean
철회신고서
M&A Activity
2025-08-01 Korean
전환가액의조정
Share Issue/Capital Change
2025-07-16 Korean
전환가액의조정 (제38회차)
Share Issue/Capital Change
2025-06-09 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2025-05-29 Korean
[기재정정]주요사항보고서(회사합병결정)
M&A Activity
2025-05-19 Korean
[기재정정]증권신고서(합병)
M&A Activity
2025-05-19 Korean
[기재정정]투자설명서
M&A Activity
2025-05-19 Korean
분기보고서 (2025.03)
Interim / Quarterly Report Q1 2025
2025-05-15 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2025-05-02 Korean
투자설명서
M&A Activity
2025-04-24 Korean
전환가액의조정 (제39회차)
Capital/Financing Update
2025-04-16 Korean
[기재정정]증권신고서(합병)
M&A Activity
2025-04-14 Korean
증권신고서(합병)
M&A Activity
2025-04-03 Korean
주주명부폐쇄기간또는기준일설정
Capital/Financing Update
2025-04-01 Korean
[첨부추가]주요사항보고서(회사합병결정)
M&A Activity
2025-04-01 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2025-03-31 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information
2025-03-31 Korean
기업설명회(IR)개최
Report Publication Announcement
2025-03-27 Korean
기업설명회(IR)개최
Report Publication Announcement
2025-03-27 Korean
기업설명회(IR)개최
Report Publication Announcement
2025-03-25 Korean
기타경영사항(자율공시) (HLB 간암 1차 치료제(리보세라닙,캄렐리주맙 병용요법)FDA로부터 보완요구서한(CRL,Complete Response Letter)수령)
Legal Proceedings Report
2025-03-21 Korean
[기재정정]기타경영사항(자율공시) (HLB 간암 1차 치료제(리보세라닙,캄렐리주맙 병용요법)FDA로부터 보완요구서한(CRL,Complete Response Letter)수령)
Legal Proceedings Report
2025-03-21 Korean
감사보고서제출
Audit Report / Information FY 2024
2025-03-21 Korean
사업보고서 (2024.12)
Annual Report FY 2024
2025-03-21 Korean
전환가액의조정 (제38회차)
Share Issue/Capital Change
2025-03-10 Korean
주주총회소집결의 (정기주주총회)
Proxy Solicitation & Information Statement
2025-03-05 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement
2025-03-05 Korean
주주총회소집공고
Proxy Solicitation & Information Statement
2025-03-05 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release FY 2024
2025-02-26 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2025-01-07 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2025-01-07 Korean